Oracle Expands Life Sciences AI Platform with Domain Agents

Oracle adds AI agents to life sciences research platform

Oracle has significantly expanded its AI-powered life sciences platform, now rebranded as Life Sciences Data Intelligence, with domain-trained AI agents and natural-language capabilities designed to accelerate clinical research and drug development workflows.

The enhancements, announced at the Oracle Health and Life Sciences Summit 2026 in Orlando, build on the company's platform originally launched in January. The updated system integrates customer data with Oracle's repository of more than 122 million longitudinal health records, creating a unified environment for evidence generation and patient identification.

Natural language meets real-world evidence

The platform's core innovation centers on allowing researchers to use natural-language queries to analyze data, build patient cohorts, and automate research workflows without extensive coding requirements. These AI-enabled features guide users through common research activities including cohort discovery, clinical trial recruitment, site optimization, and health economics research.

Crucially, the tools provide traceable reasoning and transparent audit trails, addressing a persistent concern in AI-assisted research: understanding how results were generated and validating the underlying evidence.

The cloud-native architecture gives organizations flexibility to scale as data volumes and AI use cases expand, while incorporating additional third-party datasets over time. Oracle emphasizes that the platform uses strong oversight controls to transform de-identified patient data into actionable insights.

Why it matters

Fragmented data systems remain a major bottleneck in pharmaceutical research, often adding months or years to development timelines. By combining governed real-world data with domain-specific AI in a single platform, Oracle is addressing what IDC Research Vice President Nimita Limaye calls the "trust gap" — the tension between speed and credibility that has slowed AI adoption in regulated research environments. The ability to query complex datasets in natural language while maintaining audit trails could democratize advanced analytics across research teams, not just data scientists.

Broader healthcare AI strategy

The life sciences platform expansion represents one component of Oracle's larger healthcare AI initiative. The company recently launched a next-generation EHR with embedded AI and voice capabilities, upgraded its AI-powered clinical documentation agent, and built out generative AI features for inpatient nursing workflows.

The Life Sciences Data Intelligence platform is designed to integrate across Oracle's technology ecosystem, including Oracle Cloud Infrastructure, Oracle Fusion Cloud applications, and Oracle Health solutions.

"Fragmented data and disconnected workflows continue to slow the path to discovery," said Seema Verma, executive vice president and general manager of Oracle Health and Life Sciences. The platform's combination of real-world data and domain-specific AI tools enables researchers to conduct studies and explore data in natural language, she noted.

These details were first reported by Fierce Healthcare.